economy·
For U.S. Life Sciences Real Estate, 2026 Is a Tale of Stabilization
The U.S. life sciences real estate market remains oversupplied, but improving funding conditions and a sharply reduced construction pipeline are beginning to set the stage for a recovery, according to Cushman & Wakefield. Asking rents at U.S. life sciences fa…
The U.S. life sciences real estate market remains oversupplied, but improving funding conditions and a sharply reduced construction pipeline are beginning to set the stage for a recovery, according to Cushman & Wakefield. Asking rents at U.S. life sciences fa…
Read original at Commercial Observer